Zobrazeno 1 - 10 of 35 pro vyhledávání: '"Caspar J Hodiamont"'
1
Akademický článek
Development of Antibiotic Resistance during Simulated Treatment of Pseudomonas aeruginosa in Chemostats.
Autor: Yanfang Feng, Caspar J Hodiamont, Reinier M van Hest, Stanley Brul, Constance Schultsz, Benno H Ter Kuile
Publikováno v: PLoS ONE, Vol 11, Iss 2, p e0149310 (2016)
During treatment of infections with antibiotics in critically ill patients in the intensive care resistance often develops. This study aims to establish whether under those conditions this resistance can develop de novo or that genetic exchange betwe
Externí odkaz: https://doaj.org/article/bd858ee7fc334eda92a4d90aa7c2ce54
Zobrazit plný text záznamu
2
Akademický článek
Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide.
Autor: Caspar J Hodiamont, Piet A Kager, Aldert Bart, Henry J C de Vries, Pieter P A M van Thiel, Tjalling Leenstra, Peter J de Vries, Michèle van Vugt, Martin P Grobusch, Tom van Gool
Publikováno v: PLoS Neglected Tropical Diseases, Vol 8, Iss 5, p e2832 (2014)
BACKGROUND:Leishmaniasis is increasingly reported among travellers. Leishmania species vary in sensitivity to available therapies. Fast and reliable molecular techniques have made species-directed treatment feasible. Many treatment trials have been d
Externí odkaz: https://doaj.org/article/3f689b9b774f4787a667ba961cc14aae
Zobrazit plný text záznamu
3
Akademický článek
Benzylpenicillin concentrations in umbilical cord blood and plasma of premature neonates following intrapartum doses for group B streptococcal prophylaxis
Autor: Amadou Samb, Thomas H. Dierikx, Yuma A. Bijleveld, Timo R. de Haan, Caspar J. Hodiamont, Elisabeth van Leeuwen, Anton H. L. C. van Kaam, Ron A. A. Mathôt, Douwe H. Visser
Publikováno v: Maternal Health, Neonatology and Perinatology, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Background and method Dutch obstetrics guideline suggest an initial maternal benzylpenicillin dose of 2,000,000 IU followed by 1,000,000 IU every 4 h for group-B-streptococci (GBS) prophylaxis. The objective of this study was to evaluate whe
Externí odkaz: https://doaj.org/article/f3c37e13c8184d7e9ecbf6410c3e2e96
Zobrazit plný text záznamu
4
Akademický článek
Fusariosis in patients with hematological malignancies: Two case reports
Autor: Jord W. Raymakers, Daan A.R. Castelijn, Caroline E. Rutten, Caspar J. Hodiamont
Publikováno v: Medical Mycology Case Reports, Vol 42, Iss , Pp 100602- (2023)
Immunosuppressed patients with hematological malignancies are at risk for invasive fungal infections (IFI), including infections with Fusarium species (spp.), which are increasingly reported. Particularly at risk are patients with acute myeloid leuke
Externí odkaz: https://doaj.org/article/882e31c94471457f944f5eca5e5a54e0
Zobrazit plný text záznamu
5
Akademický článek
Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection
Autor: Annabel Werumeus Buning, Caspar J. Hodiamont, Natalia M. Lechner, Margriet Schokkin, Paul W. G. Elbers, Nicole P. Juffermans, Ron A. A. Mathôt, Menno D. de Jong, Reinier M. van Hest
Publikováno v: Antibiotics, Vol 10, Iss 6, p 612 (2021)
Altered pharmacokinetics (PK) of hydrophilic antibiotics in critically ill patients is common, with possible consequences for efficacy and resistance. We aimed to describe ceftazidime population PK in critically ill patients with a proven or suspecte
Externí odkaz: https://doaj.org/article/381d4357ce0d4a829656f97088dede25
Zobrazit plný text záznamu
7
Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients
Autor: D J van Vessem, Caspar J. Hodiamont, S E Berends, R. M. Van Hest, N Hakkens, M D de Jong, Ron A. A. Mathôt, Nicole P. Juffermans
Publikováno v: Journal of antimicrobial chemotherapy, 76(11), 2941-2949. Oxford University Press
Journal of Antimicrobial Chemotherapy
Background The advocated pharmacokinetic/pharmacodynamic (PK/PD) target for vancomycin, AUC/MIC ≥ 400 mg·h/L, may not be reached with a conventional fixed starting dose of 1000 mg in critically ill patients, but increasing the dose may cause nephr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4977ba786c4a98ec0f317bd44bfb87e
http://www.scopus.com/inward/record.url?scp=85119085868&partnerID=8YFLogxK
Zobrazit plný text záznamu
8
Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients
Autor: Nicole P. Juffermans, Jasper M. Smit, Rogier R. Jansen, Bashar N. Hilderink, Wolmet E. Haksteen, Marcella C.A. Müller, Romein W. G. Dujardin, Pieter R. Tuinman, Caspar J. Hodiamont
Publikováno v: Thrombosis Research, 206, 128-130. Elsevier Limited
Thrombosis Research
Thrombosis research, 206, 128-130. Elsevier Limited
Haksteen, W E, Hilderink, B N, Dujardin, R W G, Jansen, R R, Hodiamont, C J, Tuinman, P R, Smit, J M, Müller, M C A & Juffermans, N P 2021, ' Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients ', Thrombosis Research, vol. 206, pp. 128-130 . https://doi.org/10.1016/j.thromres.2021.08.019
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef49782e02fc5a6b61848fa422673a1c
https://doi.org/10.1016/j.thromres.2021.08.019
Zobrazit plný text záznamu
9
Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review
Autor: Caspar J. Hodiamont, Annemieke K. van den Broek, Suzanne L. de Vroom, Jan M. Prins, Ron A. A. Mathôt, Reinier M. van Hest
Publikováno v: Hodiamont, C J, van den Broek, A K, de Vroom, S L, Prins, J M, Mathôt, R A A & van Hest, R M 2022, ' Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections : An Updated Review ', Clinical Pharmacokinetics, vol. 61, no. 8, pp. 1075-1094 . https://doi.org/10.1007/s40262-022-01143-0
Gentamicin is an aminoglycoside antibiotic with a small therapeutic window that is currently used primarily as part of short-term empirical combination therapy. Gentamicin dosing schemes still need refinement, especially for subpopulations where phar
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbcfa845530856c1265065af410dc498
https://pubmed.ncbi.nlm.nih.gov/35754071
Zobrazit plný text záznamu
10
Population Pharmacokinetics of Ganciclovir in Critically Ill Patients
Autor: Nicole P. Juffermans, Caspar J. Hodiamont, Reinier M. van Hest, Stefanie D. Krens, Ron A. A. Mathôt
Publikováno v: Therapeutic drug monitoring, 42(2), 295-301. Lippincott Williams and Wilkins
Therapeutic Drug Monitoring, 42, 2, pp. 295-301
Therapeutic Drug Monitoring, 42, 295-301
BACKGROUND: The pharmacokinetic (PK) data of ganciclovir (GCV), a first-line antiviral treatment for cytomegalovirus infections, in critically ill patients are limited. This study aimed at characterizing GCV population PK and interindividual variabil
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfa2700d217fb4962b7bb1d5f4dee419
https://doi.org/10.1097/ftd.0000000000000689
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje